Stephen Shaw

机构：Io Therapeutics (United States) · ORCID：0000-0001-9389-9024

发表论文 227 篇 · 总被引 19747 次 · h-index 67

代表论文

• Prespecified dose-response analysis for A Very Early Rehabilitation Trial (AVERT) (2016 · Neurology · 被引 220)
• LOK is a major ERM kinase in resting lymphocytes and regulates cytoskeletal rearrangement through ERM phosphorylation (2009 · Proceedings of the National Academy of Sciences · 被引 153)
• Phospholipase C–mediated hydrolysis of PIP2 releases ERM proteins from lymphocyte membrane (2009 · The Journal of Cell Biology · 被引 141)
• Detection of Rare Antigen-Presenting Cells through T Cell-Intrinsic Meandering Motility, Mediated by Myo1g (2014 · Cell · 被引 126)
• Constitutively active ezrin increases membrane tension, slows migration, and impedes endothelial transmigration of lymphocytes in vivo in mice (2011 · Blood · 被引 118)
• Myosin 1G Is an Abundant Class I Myosin in Lymphocytes Whose Localization at the Plasma Membrane Depends on Its Ancient Divergent Pleckstrin Homology (PH) Domain (Myo1PH) (2010 · Journal of Biological Chemistry · 被引 71)